This inventor holds 1 USPTO granted patent. Top assignee: Hollis-Eden Pharmaceuticals, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Mei Li - Innovator in Therapeutic Treatment Methods
Introduction
Mei Li is a prominent inventor based in San Diego, CA, known for her groundbreaking work in therapeutic treatment methods. With a focus on improving health outcomes for conditions such as cystic fibrosis and neutropenia, her contributions to the field of medicine are significant.
Latest Patents
Mei Li holds 1 patent for her invention related to therapeutic treatment methods. This patent involves the use of various compounds to ameliorate or treat conditions like cystic fibrosis and neutropenia. The exemplary compounds include 3β-hydroxy-17β-aminoandrost-5-ene, 3β-hydroxy-16α-fluoro-17β-aminoandrost-5-ene, and several others that demonstrate her innovative approach to medical treatment.
Career Highlights
Mei Li is currently associated with Hollis-Eden Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to finding effective solutions for complex health issues.
Collaborations
Throughout her career, Mei has collaborated with notable colleagues, including Christopher Reading and Clarence Nathaniel Ahlem. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Mei Li's contributions to therapeutic treatment methods exemplify her dedication to innovation in medicine. Her work not only addresses critical health challenges but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile